Navigation Links
Genova Diagnostics, Inc. Announces the Acquisition of Metametrix, Inc.
Date:7/11/2012

ASHEVILLE, N.C. and ATLANTA, July 11, 2012 /PRNewswire/ -- Genova Diagnostics, Inc. and Metametrix, Inc., leading clinical laboratories in applying a systems-based testing approach to the diagnosis, treatment and prevention of complex chronic disease, today announced they have combined efforts under one company. 

"We share a mission of improving the health of patients worldwide by striving to be the best provider of comprehensive and innovative clinical laboratory services. I look forward to offering my continued support in achieving our shared goals," said J. Alexander Bralley, PhD, CEO of Metametrix. Bralley will continue working in a consulting capacity in the newly aligned organization, focusing on development of next-generation testing approaches and clinical education programs.

The combined entity will provide a broader range of testing services, as well as increase the breadth of support and resources dedicated to physicians and their patients. "Consolidating our companies significantly increases our global presence. Together, we serve over 9,000 healthcare practitioners annually throughout the United States and internationally in 45 countries with our 400 employees and three locations in Asheville, North Carolina, Duluth, Georgia, and London, England. Our combined resources will allow us to expand investments in research & development, clinical trials, medical education and market expansion," said Ted Hull, Chairman and CEO of Genova Diagnostics.

Genova Diagnostics, Inc., which purchased all assets of Metametrix, Inc., will continue to operate under both brands at this time. Financial terms of the transaction were not disclosed.

About Metametrix:

Established in 1984, Metametrix is a pioneer in producing cutting-edge technology for the measurement of nutritional insufficiencies, metabolic dysfunction, microbial imbalances and toxic influences on health. Metametrix is committed to applying the latest advances in testing services to improve health worldwide. More information about Metametrix is available at www.metametrix.com.

About Genova Diagnostics:

Established in 1986, Genova Diagnostics is a leading company in applying a systems-based approach in clinical laboratory testing for the diagnosis, treatment and prevention of complex chronic disease. Systems-based testing is offered in a number of clinical areas, including gastrointestinal, nutritional, immunologic and endocrine, addressing a range of complex chronic conditions, including pre-diabetes, cardiovascular disease, nutritional deficiencies, hormone imbalances, depression, auto-immune disease, allergies, and irritable bowel syndrome. Genova has developed a lab industry leading commercial system for building markets for innovative testing by partnering clinician education with field-based consultative selling approach.


'/>"/>
SOURCE Metametrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
2. Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
3. Elsevier Announces New Editor-In-Chief for Neurobiology of Learning and Memory
4. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
5. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
6. Mesa Labs Announces New Logo
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2012 Results
8. Savient Pharmaceuticals Announces CEO Appointment and Reorganization Plan to Drive Long-Term Growth
9. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
10. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
11. Luminex Corporation Announces Agreement to Acquire GenturaDx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... 27, 2017  International Biophysics Corporation, a global medical device ... announced a 34% revenue growth in 2016 when compared to ... sales.  This growth was fueled by its AffloVest® sales in ... the expansion of its global sales of surgical product lines. ... "As we enter our 25 th year in delivering ...
(Date:2/27/2017)... PLACENTIA, Calif. , Feb. 27, 2017   ... new line of nutritional supplements using its groundbreaking new ... and 90 percent of potency through digestion per ... nutritional supplements solve the problem of nutritional waste and ... Prevent degradation during digestive processes Improve ...
Breaking Medicine Technology:
(Date:2/27/2017)... New Jersey (PRWEB) , ... February 27, 2017 , ... ... highest cancer rates, among all types and genders. And the need for advanced services ... by RWJ and its top-rated cancer care program, in collaboration with their non-profit partners ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards ... of International Social Design Awards. , The 7th A' Social Design Award ... and Institutions worldwide with realized projects and conceptual works. , The first phase ...
(Date:2/26/2017)... , ... February 26, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade ... Area consumers look for home care close to home, and by having city-specific pages, ...
(Date:2/26/2017)... ... ... IndustryArchive.Org . is announcing a new way for B2B Sellers to ... pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase a ... that B2B buyers are controlling the sales process via the Internet and that ad ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it will exhibit ... Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, ... to improve Medicaid population health management. , ODH will also have an exhibit booth ...
Breaking Medicine News(10 mins):